| scholarly article | Q13442814 |
| P2093 | author name string | Marieke van der Hart | |
| Paul Summergrad | |||
| Gregory Oxenkrug | |||
| P2860 | cites work | Experimental diabetes mellitus type 1 increases hippocampal content of kynurenic acid in rats | Q48439667 |
| Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone | Q57244071 | ||
| [Patients with type-II diabetes mellitus and neuropathy have no deficiency of vitamins A, E, beta-carotene, B1, B2, B6, B12 and folic acid] | Q58043610 | ||
| KYNURENINE PATHWAY METABOLISM IN PATIENTS WITH OSTEOPOROSIS AFTER 2 YEARS OF DRUG TREATMENT | Q58852518 | ||
| Riboflavin deficiency in children with diabetes mellitus | Q67823480 | ||
| Enhancing activity of anthranilic acid on adjuvant arthritis in rats and antibody formation in mice | Q69726173 | ||
| [Metabolism of riboflavin and B group vitamins functionally bound to it in insulin-dependent diabetes mellitus] | Q72701137 | ||
| Induction of tryptophan peroxidase of rat liver by insulin and alloxan | Q78330992 | ||
| Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown | Q24801191 | ||
| Kynurenines in the mammalian brain: when physiology meets pathology | Q27003296 | ||
| Metabolite profiles and the risk of developing diabetes | Q29615359 | ||
| Long term effect of gut microbiota transfer on diabetes development | Q35157830 | ||
| Metabolomic profiling in the prediction of gestational diabetes mellitus. | Q35597099 | ||
| Effect of oral administration of kynurenic acid on the activity of the peripheral blood leukocytes in mice | Q35631721 | ||
| Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. | Q35745963 | ||
| Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes | Q36021365 | ||
| A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice | Q36376640 | ||
| Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways | Q37188890 | ||
| Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism | Q37772960 | ||
| Overweight and obesity in youth with type 1 diabetes | Q38217367 | ||
| Epidemiological Perspectives of Diabetes | Q38364795 | ||
| Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells | Q38934693 | ||
| Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris | Q39071200 | ||
| Tryptophan metabolism in baboons: effect of riboflavin and pyridoxine deficiency | Q39180779 | ||
| Iron chelation and redox chemistry of anthranilic acid and 3-hydroxyanthranilic acid: A comparison of two structurally related kynurenine pathway metabolites to obtain improved insights into their potential role in neurological disease development | Q39630770 | ||
| Anthranilic acid as an intermediate in the biosynthesis of tryptophan by Bact. typhosum | Q39963118 | ||
| Characterization of the kynurenine pathway in human neurons | Q40046237 | ||
| Alteration of tryptophan metabolism in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis | Q42216683 | ||
| The relation between riboflavin and tryptophan metabolism, studied in the rat. | Q42952123 | ||
| IDO mediates TLR9-driven protection from experimental autoimmune diabetes. | Q43258639 | ||
| Tryptophan degradation during and after gestation | Q44943810 | ||
| P433 | issue | 5 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 365-368 | |
| P577 | publication date | 2015-09-25 | |
| P1433 | published in | Integrative molecular medicine | Q27726587 |
| P1476 | title | Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus | |
| P478 | volume | 2 |
| Q39185463 | Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. |
| Q36756944 | Anthranilic Acid: A Potential Biomarker and Treatment Target for Schizophrenia |
| Q28553594 | Antioxidant Properties of Kynurenines: Density Functional Theory Calculations |
| Q58007764 | Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case–Cohort Study |
| Q61448556 | Exploratory metabolomics of metabolic syndrome: A status report |
| Q42372999 | Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Müller Cells of Diabetic Human and Rodent Retina |
| Q36291638 | Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder |
| Q89266373 | Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes |
| Q94413573 | Peripheral Tryptophan - Kynurenine Metabolism Associated with Metabolic Syndrome is Different in Parkinson's and Alzheimer's Diseases |
| Q36123681 | Tryptophan Predicts the Risk for Future Type 2 Diabetes |
| Q41534161 | Untargeted metabolomic analysis in naturally occurring canine diabetes mellitus identifies similarities to human Type 1 Diabetes |
| Q92105552 | Untargeted metabolomic analysis in non-fasted diabetic dogs by UHPLC-HRMS |
Search more.